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Methods
Introduction
Conclusions
Curcumin, a natural polyphenolic phytochemical, is known for its wide range of biological activities, however it has an extremely low water
solubility as well as a low bioavailability, which limit its application as a bioactive ingredient in food. The use of delivery systems at nano-
scale such as nanoemulsions (NE) and solid lipid nanoparticles (SLN) has been reported as a promising mean of improving the lipophilic
bioactive compounds’ bioavailability and their physical and chemical stability. However, the knowledge of the behaviour of different
nanoformulations as well as the fate of bioactive compounds encapsulated within them in the gastrointestinal (GI) tract is of utmost
importance to either assess their safety for human consumption and to produce tailored delivery systems (i.e. with optimized bioactivity).
The aim of this work was the evaluation of the behaviour of two different bio-based nanoformulations (NE and SLN) incorporating
curcumin when submitted to an in vitro digestion and the assessment of their cytotoxicity.
Results
Enhancing curcumin bioaccessibility through different 
nanoformulations
R. F. S. Gonçalves1, J. T. Martins1, C. M. Duarte2, A. A. Vicente1, 
A. C. Pinheiro1,2,*
1Centre of Biological Engineering, University of Minho, Braga, Portugal
2Instituto de Biologia Experimental e Tecnológica, Avenida da República, Quinta-do-Marquês, Estação 
Agronómica Nacional, Apartado 12, 2781-901 Oeiras, Portugal
*anapinheiro@deb.uminho.pt
References
5th International Conference on Food Digestion 2017
Acknowledgements
Minekus, M., M. Alminger, et al. (2014). "A standardised static in vitro digestion method suitable for
food - an international consensus”. Food & Function 5(6): 1113-1124.
Ana C. Pinheiro and Joana T. Martins acknowledge the Foundation for Science and Technology
(FCT) for their fellowships (SFRH/BPD/101181/2014 and SFRH/BPD/89992/2012). This work was
supported by Portuguese Foundation for Science and Technology (FCT) under the scope of the
Project PTDC/AGR-TEC/5215/2014, of the strategic funding of UID/BIO/04469/2013 unit and
COMPETE 2020 (POCI-01-0145-FEDER-006684) and BioTecNorte operation (NORTE-01-0145-
FEDER-000004) funded by the European Regional Development Fund under the scope of
Norte2020 - Programa Operacional Regional do Norte.
University of Minho
School of Engineering
 Size and zeta potential  FFA release
 Cytotoxicity
 Bioaccessibility
 In vitro digestion
 Cytotoxiciy
• MTT viability assay
• Human colon carcinoma (Caco-2) cell line
• NE and SLN with curcumin concentration ranging from 5 to 25
µg/ml
• 𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 % =
𝐴𝐸𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙
𝐴𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
𝑥 100
(Apositive control: absorbance of medium incubated with cells; AExperimental: absorbance
of medium incubated with cells in contact with NE or SLN samples)
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Figure 1 – Size (a) and zeta potential (b) of the curcumin NE (■) and SLN (■) as they
undergo the different stages of in vitro digestion.
Figure 3 – Curcumin bioaccessibility after
in vitro digestion in NE, SLN and free.
a-cDifferent superscripts indicate significant
differences among samples (p < 0.05).• Both nanoformulations are stable at oral and
gastric conditions;
• NE are more unstable under intestinal
conditions, exhibiting a larger increase in
particle size (droplet coalescence);
• There are a pronounced differences in the
interfacial composition of initial NE and SLN and
throughout the in vitro digestion (i.e. gastric
phase).
• Curcumin bioaccessibility
has been shown to
increase 3.4 and 2.5
times when encapsulated
in NE and SLN,
respectively.
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• Higher amount of FFA
released from NE;
• Physical state of the
lipid droplets may have
influenced the extent of
hydrolysis.
Figure 2 – FFA concentration of the
curcumin NE (■) and SLN (■) before and
after the in vitro digestion. a-cDifferent
superscripts indicate significant differences
among samples (p < 0.05).
• Significant differences were observed in the behavior of lipid
droplets in the liquid (NE) and solid (SLN) states throughout the in
vitro digestion.
• Higher curcumin bioaccessibility was obtained for NE, which is
probably related to the higher release of FFA found for this
nanoformulation.
• The highest concentration of curcumin on both NE and SLN
formulations that can be used without interfere with cellular viability
is 15 µgmL-1 after 24 h of exposure.
• This work contribute to the evolution of the state-of-the-art on the
development of delivery systems with improved bioavailability and
on the application of nanotechnology-based solutions in the food
sector by gathering fundamental data on digestion and safety of
different nanoformulations.
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Figure 4 – Caco-2 cells viability exposed to free
curcumin (), NE () and SLN () assessed by
MTT assay, after incubation for 24 h. All data sets
were compared to positive control (). * p<0.05
relatively to the mean positive control.
• MTT assay results
demonstrated that NE
and SLN, after 24 h
incubation, showed no
cytotoxic effects at
curcumin concentration
lower than 15 µgmL-1.
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